About this Journal Submit a Manuscript Table of Contents
Journal of Oncology
Volume 2009 (2009), Article ID 894064, 8 pages
http://dx.doi.org/10.1155/2009/894064
Review Article

The Cancer Stem Cell Concept in Progression of Head and Neck Cancer

Department of Hematology and Medical Oncology, School of Medicine, Winship Cancer Institute, Emory University, Atlanta, GA 30322, USA

Received 13 March 2009; Accepted 14 September 2009

Academic Editor: Amanda Psyrri

Copyright © 2009 Zhuo (Georgia) Chen. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, “Global cancer statistics, 2002,” CA: A Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74–108, 2005. View at Scopus
  2. D. M. Parkin, P. Pisani, and J. Ferlay, “Global cancer statistics,” CA: A Cancer Journal for Clinicians, vol. 49, no. 1, pp. 33–64, 1999.
  3. A. Jemal, T. Murray, and E. Ward, “Cancer statistics, 2005,” CA: A Cancer Journal for Clinicians, vol. 55, no. 1, pp. 10–30, 2005.
  4. R. I. Haddad and D. M. Shin, “Recent advances in head and neck cancer,” The New England Journal of Medicine, vol. 359, no. 11, pp. 1143–1154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. S. J. Jang, I. Chiba, A. Hirai, W. K. Hong, and L. Mao, “Multiple oral squamous epithelial lesions: are they genetically related?” Oncogene, vol. 20, no. 18, pp. 2235–2242, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. X. Wang, M. Fan, X. Chen, et al., “Intratumor genomic heterogeneity correlates with histological grade of advanced oral squamous cell carcinoma,” Oral Oncology, vol. 42, no. 7, pp. 740–744, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. K. El-Naggar, K. Hurr, M. A. Luna, et al., “Intratumoral genetic heterogeneity in primary head and neck squamous carcinoma using microsatellite markers,” Diagnostic Molecular Pathology, vol. 6, no. 6, pp. 305–308, 1997. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Jin, Y. Jin, J. Wennerberg, et al., “Karyotypic heterogeneity and clonal evolution in squamous cell carcinomas of the head and neck,” Cancer Genetics and Cytogenetics, vol. 132, no. 2, pp. 85–96, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. H.-R. Choi, E. M. Sturgis, D. I. Rosenthal, et al., “Sarcomatoid carcinoma of the head and neck: molecular evidence for evolution and progression from conventional squamous cell carcinomas,” American Journal of Surgical Pathology, vol. 27, no. 9, pp. 1216–1220, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. I. J. Fidler and M. L. Kripke, “Metastasis results from preexisting variant cells within a malignant tumor,” Science, vol. 197, no. 4306, pp. 893–895, 1977. View at Scopus
  11. G. Heppner, K. Yamashina, B. Miller, and F. Miller, “Tumor heterogeneity in metastasis,” Progress in Clinical and Biological Research, vol. 212, pp. 45–59, 1986. View at Scopus
  12. M. F. Clarke, J. E. Dick, P. B. Dirks, et al., “Cancer stem cells—perspectives on current status and future directions: AACR workshop on cancer stem cells,” Cancer Research, vol. 66, no. 19, pp. 9339–9344, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Reya, S. J. Morrison, M. F. Clarke, and I. L. Weissman, “Stem cells, cancer, and cancer stem cells,” Nature, vol. 414, no. 6859, pp. 105–111, 2001. View at Publisher · View at Google Scholar · View at Scopus
  14. D. M. Owens and F. M. Watt, “Contribution of stem cells and differentiated cells to epidermal tumours,” Nature Reviews Cancer, vol. 3, no. 6, pp. 444–451, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. B. J. P. Huntly and D. G. Gilliland, “Cancer biology: summing up cancer stem cells,” Nature, vol. 435, no. 7046, pp. 1169–1170, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Dalerba, R. W. Cho, and M. F. Clarke, “Cancer stem cells: models and concepts,” Annual Review of Medicine, vol. 58, pp. 267–284, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. J. E. Visvader and G. J. Lindeman, “Cancer stem cells in solid tumours: accumulating evidence and unresolved questions,” Nature Reviews Cancer, vol. 8, no. 10, pp. 755–768, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke, “Prospective identification of tumorigenic breast cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 3983–3988, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Eramo, F. Lotti, G. Sette, et al., “Identification and expansion of the tumorigenic lung cancer stem cell population,” Cell Death and Differentiation, vol. 15, no. 3, pp. 504–514, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. C. J. Lee, C. Li, and D. M. Simeone, “Human pancreatic cancer stem cells: implications for how we treat pancreatic cancer,” Translational Oncology, vol. 1, no. 1, pp. 14–18, 2008.
  21. S. K. Singh, C. Hawkins, I. D. Clarke, et al., “Identification of human brain tumour initiating cells,” Nature, vol. 432, no. 7015, pp. 396–401, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. A. T. Collins, P. A. Berry, C. Hyde, M. J. Stower, and N. J. Maitland, “Prospective identification of tumorigenic prostate cancer stem cells,” Cancer Research, vol. 65, no. 23, pp. 10946–10951, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. C. F. Bender Kim, E. L. Jackson, A. E. Woolfenden, et al., “Identification of bronchioalveolar stem cells in normal lung and lung cancer,” Cell, vol. 121, no. 6, pp. 823–835, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. D. Fang, T. K. Nguyen, K. Leishear, et al., “A tumorigenic subpopulation with stem cell properties in melanomas,” Cancer Research, vol. 65, no. 20, pp. 9328–9337, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Xin, D. A. Lawson, and O. N. Witte, “The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 19, pp. 6942–6947, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. L. Patrawala, T. Calhoun, R. Schneider-Broussard, et al., “Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells,” Oncogene, vol. 25, no. 12, pp. 1696–1708, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Li, D. G. Heidt, P. Dalerba, et al., “Identification of pancreatic cancer stem cells,” Cancer Research, vol. 67, no. 3, pp. 1030–1037, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Ricci-Vitiani, A. Pagliuca, E. Palio, A. Zeuner, and R. De Maria, “Colon cancer stem cells,” Gut, vol. 57, no. 4, pp. 538–548, 2008.
  29. Z. F. Yang, D. W. Ho, M. N. Ng, et al., “Significance of CD90+ cancer stem cells in human liver cancer,” Cancer Cell, vol. 13, no. 2, pp. 153–166, 2008.
  30. T. Schatton, G. F. Murphy, N. Y. Frank, et al., “Identification of cells initiating human melanomas,” Nature, vol. 451, no. 7176, pp. 345–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Dalerba, S. J. Dylla, I.-K. Park, et al., “Phenotypic characterization of human colorectal cancer stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 24, pp. 10158–10163, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. P. C. Hermann, S. L. Huber, T. Herrler, et al., “Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer,” Cell Stem Cell, vol. 1, no. 3, pp. 313–323, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. L. Patrawala, T. Calhoun, R. Schneider-Broussard, et al., “Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic,” Cancer Research, vol. 65, no. 14, pp. 6207–6219, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Charafe-Jauffret, F. Monville, C. Ginestier, et al., “Cancer stem cells in breast: current opinion and future challenges,” Pathobiology, vol. 75, no. 2, pp. 75–84, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. L. L. Campbell and K. Polyak, “Breast tumor heterogeneity: cancer stem cells or clonal evolution?” Cell Cycle, vol. 6, no. 19, pp. 2332–2338, 2007. View at Scopus
  36. M. S. Wicha, “Cancer stem cell heterogeneity in hereditary breast cancer,” Breast Cancer Research, vol. 10, no. 2, p. 105, 2008. View at Scopus
  37. M. Shipitsin, L. L. Campbell, P. Argani, et al., “Molecular definition of breast tumor heterogeneity,” Cancer Cell, vol. 11, no. 3, pp. 259–273, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, and M. F. Clarke, “Prospective identification of tumorigenic breast cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 7, pp. 3983–3988, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Bao, Q. Wu, R. E. McLendon, et al., “Glioma stem cells promote radioresistance by preferential activation of the DNA damage response,” Nature, vol. 444, no. 7120, pp. 756–760, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. C. A. O'Brien, A. Pollett, S. Gallinger, and J. E. Dick, “A human colon cancer cell capable of initiating tumour growth in immunodeficient mice,” Nature, vol. 445, no. 7123, pp. 106–110, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. L. Ricci-Vitiani, D. G. Lombardi, E. Pilozzi, et al., “Identification and expansion of human colon-cancer-initiating cells,” Nature, vol. 445, no. 7123, pp. 111–115, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. M. A. Goodell, K. Brose, G. Paradis, A. S. Conner, and R. C. Mulligan, “Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo,” Journal of Experimental Medicine, vol. 183, no. 4, pp. 1797–1806, 1996. View at Publisher · View at Google Scholar · View at Scopus
  43. D. G. Tang, L. Patrawala, T. Calhoun, et al., “Prostate cancer stem/progenitor cells: identification, characterization, and implications,” Molecular Carcinogenesis, vol. 46, no. 1, pp. 1–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Dell'Albani, “Stem cell markers in gliomas,” Neurochemical Research, vol. 33, no. 12, pp. 2407–2415, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. M. Dean, T. Fojo, and S. Bates, “Tumour stem cells and drug resistance,” Nature Reviews Cancer, vol. 5, no. 4, pp. 275–284, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. N. A. Dallas, L. Xia, F. Fan, et al., “Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition,” Cancer Research, vol. 69, no. 5, pp. 1951–1957, 2009. View at Publisher · View at Google Scholar · View at Scopus
  47. C. Hirschmann-Jax, A. E. Foster, G. G. Wulf, et al., “A distinct “side population” of cells with high drug efflux capacity in human tumor cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 39, pp. 14228–14233, 2004. View at Publisher · View at Google Scholar · View at Scopus
  48. A. R. Tan, G. Alexe, and M. Reiss, “Transforming growth factor-β signaling: emerging stem cell target in metastatic breast cancer?” Breast Cancer Research and Treatment, vol. 115, no. 3, pp. 453–495, 2008.
  49. D. C. Radisky and M. A. LaBarge, “Epithelial-mesenchymal transition and the stem cell phenotype,” Cell Stem Cell, vol. 2, no. 6, pp. 511–512, 2008. View at Publisher · View at Google Scholar · View at Scopus
  50. T. Brabletz, A. Jung, S. Spaderna, F. Hlubek, and T. Kirchner, “Opinion: migrating cancer stem cells—an integrated concept of malignant tumour progression,” Nature Reviews Cancer, vol. 5, no. 9, pp. 744–749, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. T. Brabletz, F. Hlubek, S. Spaderna, et al., “Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and β-catenin,” Cells Tissues Organs, vol. 179, no. 1-2, pp. 56–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. S. A. Mani, W. Guo, M.-J. Liao, et al., “The epithelial-mesenchymal transition generates cells with properties of stem cells,” Cell, vol. 133, no. 4, pp. 704–715, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. P. C. Hermann, S. L. Huber, and C. Heeschen, “Metastatic cancer stem cells: a new target for anti-cancer therapy?” Cell Cycle, vol. 7, no. 2, pp. 188–193, 2008. View at Scopus
  54. L. Patrawala, T. Calhoun-Davis, R. Schneider-Broussard, and D. G. Tang, “Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+α2β1+ cell population is enriched in tumor-initiating cells,” Cancer Research, vol. 67, no. 14, pp. 6796–6805, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. C. Odoux, H. Fohrer, T. Hoppo, et al., “A stochastic model for cancer stem cell origin in metastatic colon cancer,” Cancer Research, vol. 68, no. 17, pp. 6932–6941, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. M. E. P. Prince and L. E. Ailles, “Cancer stem cells in head and neck squamous cell cancer,” Journal of Clinical Oncology, vol. 26, no. 17, pp. 2871–2875, 2008. View at Publisher · View at Google Scholar · View at Scopus
  57. M. E. Prince, R. Sivanandan, A. Kaczorowski, et al., “Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 3, pp. 973–978, 2007. View at Publisher · View at Google Scholar · View at Scopus
  58. A. Okamoto, K. Chikamatsu, K. Sakakura, et al., “Expansion and characterization of cancer stem-like cells in squamous cell carcinoma of the head and neck,” Oral Oncology, vol. 45, no. 7, pp. 633–639, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. P. Zhang, Y. Zhang, L. Mao, Z. Zhang, and W. Chen, “Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes,” Cancer Letters, vol. 277, no. 2, pp. 227–234, 2009. View at Publisher · View at Google Scholar · View at Scopus
  60. S.-H. Chiou, C.-C. Yu, C.-Y. Huang, et al., “Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma,” Clinical Cancer Research, vol. 14, no. 13, pp. 4085–4095, 2008. View at Publisher · View at Google Scholar · View at Scopus
  61. X. D. Wei, L. Zhou, L. Cheng, et al., “In vivo investigation of CD133 as a putative marker of cancer stem cells in hep-2 cell line,” Head and Neck, vol. 31, no. 1, pp. 94–101, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. S. J. Miller, R. M. Lavker, and T.-T. Sun, “Interpreting epithelial cancer biology in the context of stem cells: tumor properties and therapeutic implications,” Biochimica et Biophysica Acta, vol. 1756, no. 1, pp. 25–52, 2005. View at Publisher · View at Google Scholar · View at Scopus
  63. M. J. Bissell and M. A. Labarge, “Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?” Cancer Cell, vol. 7, no. 1, pp. 17–23, 2005. View at Publisher · View at Google Scholar · View at Scopus
  64. D. M. Owens and F. M. Watt, “Contribution of stem cells and differentiated cells to epidermal tumours,” Nature Reviews Cancer, vol. 3, no. 6, pp. 444–451, 2003. View at Publisher · View at Google Scholar · View at Scopus
  65. X. Zhang, Y. Liu, M. Z. Gilcrease, et al., “A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line,” Cancer, vol. 95, no. 8, pp. 1663–1672, 2002. View at Publisher · View at Google Scholar · View at Scopus
  66. Y. Yoon, Z. Liang, X. Zhang, et al., “CXC chemokine receptor-4 antagonist blocks both growth of primary tumor and metastasis of head and neck cancer in xenograft mouse models,” Cancer Research, vol. 67, no. 15, pp. 7518–7524, 2007. View at Publisher · View at Google Scholar · View at Scopus
  67. X. Zhang, L. Su, A. A. Pirani, et al., “Understanding metastatic SCCHN cells from unique genotypes to phenotypes with the aid of an animal model and DNA microarray analysis,” Clinical and Experimental Metastasis, vol. 23, no. 3-4, pp. 209–222, 2006. View at Publisher · View at Google Scholar · View at Scopus
  68. S. M. Janes and F. M. Watt, “New roles for integrins in squamous-cell carcinoma,” Nature Reviews Cancer, vol. 6, no. 3, pp. 175–183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  69. S. C. Kirkland and H. Ying, “α2β1 integrin regulates lineage commitment in multipotent human colorectal cancer cells,” Journal of Biological Chemistry, vol. 283, no. 41, pp. 27612–27619, 2008. View at Publisher · View at Google Scholar · View at Scopus
  70. B. Mack and O. Gires, “CD44s and CD44v6 expression in head and neck epithelia,” PLoS ONE, vol. 3, no. 10, article e3360, 2008. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Ginestier, M. H. Hur, E. Charafe-Jauffret, et al., “ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome,” Cell Stem Cell, vol. 1, no. 5, pp. 555–567, 2007. View at Publisher · View at Google Scholar · View at Scopus
  72. C. Visus, D. Ito, A. Amoscato, et al., “Identification of human aldehyde dehydrogenase 1 family member a1 as a novel CD8+ T-cell-defined tumor antigen in squamous cell carcinoma of the head and neck,” Cancer Research, vol. 67, no. 21, pp. 10538–10545, 2007. View at Publisher · View at Google Scholar · View at Scopus
  73. M. E. Davis, Z. Chen, and D. M. Shin, “Nanoparticle therapeutics: an emerging treatment modality for cancer,” Nature Reviews Drug Discovery, vol. 7, no. 9, pp. 771–782, 2008. View at Publisher · View at Google Scholar · View at Scopus